Editorial
Organosilicon polymer-derived ceramics strategy has emerged a number of advantages in fabricating bioceramics for bone tissue engineering [1, 2] . In traditional, the fabrication processes of silicate bioceramics including preparation of raw materials, shaping, porosity making and sintering. However, solid state reaction, sol-gel as well as other common methods are either high-energy consumption or difficult in processing and shaping. Fortunately, organosilicon polymers have been synthesized for fabricating silicate bioceramics in recent decades. The fabrication of organosilicon polymer-derived bioceramics involves cross-linking, pyrolysis and ceramization. In order to obtain silicate bioceramics, active fillers are added and they can react with silicon during polymer pyrolysis. One of the most important advantages for polymer-derived silicate bioceramics strategy is the combination of shaping with synthesis and the dispersity of active filers in polymer solution, which is better than that in solid environment, resulting in a decrease of sintering temperature as well.
To date, a variety of silicate bioceramics including calcium-based silicates (CaO•SiO 2 , 2CaO•SiO 2 ), forsterite (2MgO•SiO 2 ), mullite (3Al 2 O 3 ·2SiO 2 ), zircon (ZrO 2 •SiO 2 ), willemite (2ZnO•SiO 2 ), and ternary silicates such as akermanite (2CaO·MgO·2SiO 2 ), diopside (CaO·MgO·2SiO 2 ), hardystonite (2CaO·ZnO·2SiO 2 ), gehlenite (2CaO•Al 2 O 3 •SiO 2 ), cordierite (2MgO•2Al 2 O 3 •5SiO 2 ) have been successfully fabricated via polymer-derived strategy. As known, most of silicate bioceramics have been developed for bone tissue engineering due to their outstanding bioactivity [3] .
As the commonest silicate bioceramics, wollastonite (CaSiO 3 ) was first fabricated via the polymer-derived strategy by Bernardo et al. [4, 5] . Different organosilicon polymers and calcium sources such as CaCO 3 , Ca(OH) 2 , CaO were used, and wollastonite could be synthesized beyond 1000°C. The crystallinity of wollastonite was influenced by the particle size of calcium sources, and the smaller sized active fillers with higher surface area led to a better crystallinity. Similarly, β-Ca 2 SiO 4 could be fabricated from silicone resin loaded with CaCO 3 active fillers [1] . β-Ca 2 SiO 4 phase could be formed over 900°C sintering and the crystallinity of the ceramic scaffolds increased with increasing the sintering temperature. Furthermore, ternary silicates such as hardstonite (Ca 2 ZnSi 2 O 7 ) [6, 7] and akermanite (Ca 2 MgSi 2 O 7 ) [8] were also fabricated from the same organosilicon polymers loaded with CaCO 3 active fillers, in which ZnO and Mg(OH) 2 acted as second active fillers, respectively. Fiocco et al. [9] fabricated bioactive glasses (BG) derived from organosilicon polymers and active fillers. By adjusting the proportion such as CaCO 3 , Na 2 CO 3 and Na 2 HPO 4 ·7H 2 O, 45S5 and 58S bioactive glasses were fabricated from the reaction between silica and active fillers at 1000°C. Therefore, most of silicate bioceramics can be fabricated via polymer-derived strategy from organosilicon polymers loaded with different active fillers in a specific ratio.
Based on these studies, there are many researches about silicate composites derived from polymers. Hydroxyapatite (HA) is a naturally mineral form of calcium phosphate and bioactive glass (BG) are bioactive in vivo for bone regeneration, which have been widely used for improving the biological property [10, 11] . For example, wollastonite/ hydroxyapatite and wollastonite/AP40 BG composites have been fabricated from organosilicon polymer loaded with CaCO 3 active fillers, while hydroxyapatite and bioactive glass were as passive fillers [12, 13] . Besides improving biological properties, the passive fillers can provide a smaller shrinkage during ceramization. Elsayed et al. and Fiocco et al. [14] [15] [16] [17] fabricated wollastonite/diopside composite with a molar ratio of 1:1. CaCO 3 and Mg(OH) 2 were used as both active fillers and reacted with organosilicon polymers at 1100°C to form wollastonite and diopside phases.
Except for component, porosity is another vital factor for bioceramics, which facilitates cell attachment, migration as well as flow transport of nutrients and bone ingrowth. The addition of foaming agents in starting materials is a common method to fabricate porous silicate bioceramics. Common foaming agents include polyurethane (PU), borax (Na 2 B4O 7 ·10H 2 O), sodium borate, sodium phosphate dibasic heptahydrate (Na 2 HPO 4 ·7H 2 O), dicarbamoylhydrazine (DCH), polymethyl methacrylate (PMMA), Pluronic P123, etc [18] . However, residual foams or impurities may damage the silicate bioceramics, and these traditional methods cannot provide a well pore interconnection, proper pore size or high porosity. In recent years, 3D printing has been developed and is able to create a complex porous structure for polymerderived silicate bioceramics [19, 20] .
The process of fabricating organosilicon polymer-derived silicate bioceramics is easily combined with 3D printing due to the regulated rheological property of polymers. Direct ink writing was first employed to shape organosilicon polymers to obtain wollastonite. A printable paste was prepared firstly by mixing CaCO 3 into polymer solution for 3D printing, and then the wollastonite was obtained after a sintering process. Porous hardystonite (Ca 2 ZnSi 2 O 7 ) were fabricated by direct ink writing by Zocca et al. [6] . ZnO and CaCO 3 powders were mixed into organosilicon polymer solution to form a printable ink. The final hardstonite scaffolds possesses large porosity (>76%) with a compressive strength of ca. 2.5 MPa. Similarly, wollastonite/diopside composite scaffolds were successfully fabricated by the same method, and the obtained scaffold possesses large porosity (68%-76%) with a compressive strength (3.9-4.9 MPa). On the other hand, Zocca et al. [12] fabricated wollastonite/AP40 BG scaffolds by powder-based 3D printing. Polysiloxane as an organosilicon polymer, CaCO 3 and AP40 bioactive glass powders were used as each deposit layer (150 μm). A mixture of 1-hexanol and hexylacetate was used as a printing liquid. After layer-by-layer shaping and sintering, the obtained composite scaffolds possess a porosity of 80% and a biaxial flexural strength of ca. 6 MPa.
Subsequently, the biological property of silicate bioceramics is also important and many related studies on organosilicon polymer-derived silicate bioceramics. Human osteoblast and fibroblast cells have been used to evaluate the cell compatibility for those organosilicon polymerderived bioceramic scaffolds, which showed good bioactivity and the ability for cell adhesion, proliferation and differentiation.
In general, organosilicon polymer-derived bioceramics strategy has been developed for bone tissue engineering due to its low-energy consumption and easy for shaping. To fabricate the silicate bioceramics derived from organosilicon polymers, there are four main processes including the preparation of raw materials, shaping, cross-linking and sintering. Different organosilicon polymers and fillers decide the final component of bioceramics. However, there is no denying that the shrinkage and cracks of the organosilicon polymer-derived silicate bioceramics cannot be controlled precisely. Combining with 3D printing technique, the obtained silicate bioceramics are more suitable for application in bone tissue engineering. In future, the development of organosilicon polymers can fabricate other functional bioceramics, such as borate and phosphate ceramics, and 3D printing provides bioceramics with promising porous structures for bone tissue engineering.
